ArticlePloS one2021
A structure-based engineering approach to abrogate pre-existing antibody binding to biotherapeutics.
Joanne Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
15 papers cite it
this papercites it
ArticlePloS one2021
Joanne Lin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.